4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-016981
Options or other derivatives
- Chief Operating Officer acquired 36,983 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Williams Paul Christopher Chief Operating Officer | 2023-03-03 | Grant or award · Employee Stock option (right to buy) | +22,257 | 22,257 | D | ||
| Williams Paul Christopher Chief Operating Officer | 2023-03-03 | Grant or award · Restricted Stock Units | +14,726 | 14,726 | D | ||
Loading xslF345X03/doc4.xml…